Aesthetics

This week in aesthetics, we announce our Summer issue, highlight female to male top surgery protocols, and more.

In this Summer issue, Paul Nassif, MD, gives his advice on how to create a successful skin care brand, Joe Niamtu, III, DMD, shares how to safeguard the practice from scams when donating to charitable organizations, and Gary Linkov, MD, shares his protocol for facial hair transplants.

Combining microwave and microablative CO2 laser treatment is both safe and effective for treating postpartum abdominal laxity.

Mark Mandell-Brown, MD, details his treatment protocol for addressing female to male breast reduction surgically and through minimally invasive procedures.

This week, consumer magazines highlight plastic surgeons accepting cryptocurrency, the difference between top surgery and a mastectomy, and more.

This week in aesthetics, we highlight the FDA approval of Restylane Contour, a guide to Aesthetics Biomedical’s upcoming “The Evolution of Aesthetics” symposium, and more.

A study compared the results of single-plane vs double-plane microfocused ultrasound with visualization (MFU-V) for upper arm skin laxity treatment.

Hair regrowth was observed after starting dupilumab treatment in some pediatric patients with a history of severe and refractory alopecia areata (AA) and concomitant atopic dermatitis (AD).

With in-person conferences coming out of the shadows and into the light once again, we detail a guide to Aesthetics Biomedical’s “Perspectives. The Evolution of Aesthetics” symposium happening July 24.

Dermatologists are expanding their skill sets and exploring new techniques to enable gender-diverse patients to achieve their medical and aesthetic goals.

Galderma receives Restylane Contour FDA approval for cheek augmentation and correction of midface contour deficiencies.

Advanced Aesthetic Technologies, Inc, announces start of Algeness VL clinical trial in China seeking future market approval.

This week, consumer magazines highlight 2 Black trans women’s fight for gender-affirming surgery under Medicaid, beauty secrets from Indian women, and more.

A recent study investigated the use of a microneedling radiofrequency device in improving skin laxity and fat deposits in patients.

Endo Aesthetics’ QWO data to be presented at the Cosmetic Bootcamp Summer Event from June 24-27, 2021.

This week in aesthetics, we highlight nano-pulse stimulation energy on facial tissue and wound response, a look inside Refresh Dermatology, and more.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, discusses allergies from skin care products and how to prevent adverse reactions.

Take a look inside Suneel Chilukuri, MDs, Refresh Dermatology practice as he discusses patient retention and demonstrates his QWO cellulite treatment protocol in office.

A 2020 study examines techniques used to visualize facial arteries as a response to an increase in filler-associated complications due to intra-arterial injection.

In his latest editorial, Randolph Waldman, MD, discusses the challenges of running an independent medical practice, including cybercrime, employee deficits, and the threat of escalating tax burden.

Vivace microneedling device receives FDA clearance on 2MHz radiofrequency setting.

New TrichoTest aims to help clinicians diagnose and treat alopecia.

Vivace microneedling device receives FDA clearance on 2MHz radiofrequency setting.

A 2020 study investigates the safety and efficacy of nanopulse stimulation energy on facial tissue and wound response.

This week, consumer magazines highlight psychodermatology, thread lifts, and more.

This week in aesthetics, we highlight the launch of Nutrafol Postpartum, the creation of the AACS Women in Cosmetic Surgery forum, and more.

The American Academy of Cosmetic Surgery announced the creation of a new forum, WICS, focused on the growth and development of female cosmetic surgeon members.

Hugel America announces the FDA has approved the BLA application for letibotulinumtoxinA as a treatment for glabellar lines in adult patients.

Hugel America announces the BLA application FDA approval for letibotulinumtoxinA as a treatment for glabellar lines in adult patients.

Nutrafol launches a new nutraceutical, called Postpartum, aimed at helping women’s hair health post-pregnancy.